Fate Therapeutics, Inc. (FATE) key performance indicators and operating metrics (3 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Total Operating Expenses Net of Non-Cash Share-Based Compensation | 34.3M | FY2026-Q1 |
| Non-Cash Share-Based Compensation Expense Included in Operating Expenses | 3.9M | FY2026-Q1 |
| FT819-102 Clinical Sites With Enrollment | 18.00 | FY2026-Q1 |
Back to FATE overview · FATE earnings · FATE holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.